Search Within

Lilian M Reich

Formats
  1. Meeting Abstract (49)
  2. Journal Article (45)
  3. Conference Paper (4)
  4. Book Section (1)
Groups
  1. Department of Medicine (99)
  2. Hematologic Malignancies, Division of (99)
  3. Center for Hematologic Malignancies (47)
  4. Sloan Kettering Institute Faculty (31)
  5. Solid Tumor Oncology Division (31)
  6. Survivorship Research (28)

More Groups

People
  1. Stephen Nimer (26)
  2. Raymond Comenzo (22)
  3. Larry Norton (21)
  4. Hani Hassoun (20)
  5. John Crown (19)
  6. Martin Fleisher (17)

More People

Years
  1. 2017 (1)
  2. 2016 (2)
  3. 2015 (1)
  4. 2014 (2)
  5. 2013 (5)
  6. 2012 (1)

More Years

Publications
  1. Blood (39)
  2. Bone Marrow Transplantation (11)
  3. Journal of Clinical Oncology (9)
  4. Transfusion (4)
  5. Artificial Organs (3)
  6. Biology of Blood and Marrow Transplantation (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Nature Publishing Group (13)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Inc. (7)
  5. American Association for Cancer Research (5)
  6. Blackwell Publishing (4)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long-term hematopoiesis is not affected by rapid cycling of sequential high dose chemotherapy (HDC) prior to full hematologic recovery
    Meeting Abstract

    Tiersten, A.; Raptis, G.; Crown, J.; Vahdat, L.; Hamilton, N.; Reich, L.; Damaskos, P.; Norton, L.
    Blood (1994)

    Fulltext@MSK | Save
  • Comparative efficacy of bone marrow engraftment following high-dose (HD) carboplatin (CBDCA) plus cyclophosphamide versus high-dose CBDCA/Taxol (TXL), when rescued with TXL cyclophosphamide (CPA) and GCSF mobilized peripheral blood progenitor cells (PBP)
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Schneider, J.; Spriggs, D.; Bengala, C.; McKenzie, M.; Reich, L.; Norton, L.; Moore, M. A. S.; Crown, J.
    Blood (1994)

    Fulltext@MSK | Save
  • High-intensity chemotherapy with peripheral blood progenitor cell support
    Conference Paper

    Fennelly, D.; Vahdat, L.; Schneider, J.; Reich, L.; Hamilton, N.; Hakes, T.; Raptis, G.; Wasserheit, C.; Kritz, A.; Gulati, S.; more...
    Elsevier Inc. (1994)

    Fulltext@MSK | Save
  • Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: A phase I trial
    Journal Article

    Fennelly, D.; Wasserheit, C.; Schneider, J.; Hakes, T.; Reich, L.; Curtin, J.; Yao, T. J.; Markman, M.; Norton, L.; Crown, J.
    Cancer Research (1994)

    Fulltext@MSK | Save
  • Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients
    Journal Article

    Schneider, J. G.; Crown, J. P.; Wasserheit, C.; Kritz, A.; Wong, G.; Reich, L.; Norton, L.; Moore, M. A. S.
    Bone Marrow Transplantation (1994)

    Fulltext@MSK | Save
  • Optimization of conditions for ex vivo expansion of CD34(+) cells from patients with stage IV breast cancer
    Journal Article

    Shapiro, F.; Yao, T. J.; Raptis, G.; Reich, L.; Norton, L.; Moore, M. A. S.
    Blood (1994)

    Fulltext@MSK | Save
  • Ex-vivo expansion of CD34(+) cells: A comparison of 20% fetal calf serum to various concentrations of autologous plasma or serum in gas-permeable bags
    Meeting Abstract

    Shapiro, F.; Bengala, C.; Schneider, J.; Reich, L.; Vahdat, L.; Fennelly, D.; Raptis, G.; Norton, L.; Heimfeld, S.; Berenson, R.; more...
    Blood (1993)

    Fulltext@MSK | Save
  • Superiority of high dose cyclophosphamide + GCSF versus either lower dose cyclophosphamide + GCSF or GCSF alone in mobilization of peripheral blood progenitor cells
    Meeting Abstract

    Vahdat, L.; Raptis, G.; Fennelly, D.; Reich, L.; Hamilton, N.; Yao, T. J.; Norton, L.; Gulati, S.; Crown, J.
    Blood (1993)

    Fulltext@MSK | Save
  • Peripheral blood progenitor supported high-dose chemotherapy: Determination of a threshold number of CD34+ cells for reliable engraftment
    Meeting Abstract

    Raptis, G.; Vahdat, L.; Fennelly, D.; Reich, L.; Hamilton, N.; Yao, T. J.; Bengala, C.; Schneider, J.; Shapiro, F.; Gulati, S.; more...
    Blood (1993)

    Fulltext@MSK | Save
  • Taxol (TXL) in combination with cyclophosphamide (CTX) and G-CSF can improve the mobilization of peripheral blood progenitors cells (PBPCs) in untreated locally advanced ovarian cancer: Preliminary report
    Meeting Abstract

    Bengala, C.; Fennelly, D.; Shapiro, F.; Schneider, J.; Reich, L.; Moore, M. A. S.; Norton, L.; Crown, J.
    Blood (1993)

    Fulltext@MSK | Save